OXB vs. ONT, GNS, ERGO, SLN, PRTC, HZD, FARN, VRP, ARIX, and 4BB
Should you be buying Oxford Biomedica stock or one of its competitors? The main competitors of Oxford Biomedica include Oxford Nanopore Technologies (ONT), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), and 4basebio (4BB). These companies are all part of the "biotechnology" industry.
Oxford Biomedica vs.
Oxford Nanopore Technologies (LON:ONT) and Oxford Biomedica (LON:OXB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.
Oxford Biomedica has lower revenue, but higher earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Oxford Biomedica, indicating that it is currently the more affordable of the two stocks.
In the previous week, Oxford Biomedica had 1 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 1 mentions for Oxford Biomedica and 0 mentions for Oxford Nanopore Technologies. Oxford Biomedica's average media sentiment score of 0.75 beat Oxford Nanopore Technologies' score of 0.00 indicating that Oxford Biomedica is being referred to more favorably in the news media.
38.4% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 64.1% of Oxford Biomedica shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by company insiders. Comparatively, 21.2% of Oxford Biomedica shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Oxford Biomedica received 325 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 66.73% of users gave Oxford Biomedica an outperform vote.
Oxford Nanopore Technologies has a net margin of -94.82% compared to Oxford Biomedica's net margin of -145.98%. Oxford Nanopore Technologies' return on equity of -26.02% beat Oxford Biomedica's return on equity.
Oxford Nanopore Technologies presently has a consensus target price of GBX 233.33, indicating a potential upside of 91.89%. Oxford Biomedica has a consensus target price of GBX 560, indicating a potential upside of 91.78%. Given Oxford Nanopore Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than Oxford Biomedica.
Oxford Nanopore Technologies has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Oxford Biomedica has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500.
Summary
Oxford Nanopore Technologies beats Oxford Biomedica on 10 of the 18 factors compared between the two stocks.
Get Oxford Biomedica News Delivered to You Automatically
Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Biomedica Competitors List
Related Companies and Tools
This page (LON:OXB) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy OXB Stock Free OXB Stock Alerts